SDZXF News and Press, Sandoz Group Ag Shs

2026-02-25 07:31:30 ET Sandoz Group AG (SDZNY) Q4 2025 Earnings Call February 25, 2026 3:30 AM EST Company Participants Craig Marks - Head of Investor Relations Richard Saynor - Chief Executive Officer Remco Steenbergen - Chief Financial Officer ... Read ...

2026-02-18 05:09:27 ET More on Sandoz Group AG Sandoz: The Share Price May Have Run Its Course Sandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Sandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Confere...

2026-02-05 10:30:00 ET Introduction Right before "Liberation Day," I published a positive article on Sandoz ( SDZNY ) (SDZXF), and I took advantage of the share price dip upon the announcement of the US tariffs to initiate a substantial long position. I have alread...

2026-01-13 15:46:01 ET Sandoz Group AG (SDZNY) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 12:45 PM EST... Read the full article on Seeking Alpha For further details see: Sandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Tra...

2025-10-30 07:36:24 ET Sandoz Group AG (SDZNY) Q3 2025 Sales Call October 30, 2025 4:00 AM EDT Company Participants Craig Marks - Head of Investor Relations Richard Saynor - Chief Executive Officer Remco Steenbergen - Chief Financial Officer ... Read the ...

2025-10-29 15:56:39 ET More on Amgen, Teva Pharmaceutical Teva Vs. Viatris: Who Will Dominate In President Trump's America? Teva Pharmaceutical: Turnaround Driven By Huge Pipeline Upside Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors Ea...

2025-10-10 11:07:52 ET More on Pfizer Pfizer's Q3: The Catalyst For A Bullish Resurgence (Earnings Preview) Pfizer: Mastering The Art Of The Deal With Metsera - Upgraded To Buy Why The Pfizer-Trump Pharma Deal Is A Win For Branded Pharma, But Not For Consumers ...

2025-10-09 10:54:54 ET Since my article "Biogen: Investors Are Missing the Bigger Picture," which provoked a sharp reaction primarily from investors and traders pessimistic about Biogen's long-term outlook (NASDAQ: BIIB ), its stock price has risen 19%.... Read the full ar...

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...

2025-09-25 11:42:45 ET Just over four months have passed since the publication of my last article , "Why Investors Should Watch Teva Despite Regional Risks," and during that time, the Teva Pharmaceutical Industries Limited (TEVA) share price has risen by 14%.... Read the full ...